Hyperrab 300 unit/ML vial 5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQS9W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,669
Award facts
- Contract value 100% obligated
- $8,668.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of HYPERRAB 300 Unit/ML vial in 5ML quantities, with a ceiling value of $8,668.70 and a completion date of January 21, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies the Defense Logistics Agency and military healthcare systems with a comprehensive range of pharmaceutical products and medical supplies. The company maintains an extensive portfolio of competitively awarded federal contracts covering medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for HYPERRAB—a rabies immune globulin product—supports the Defense Health Agency and military healthcare requirements through the company's prime vendor vehicle, demonstrating its role as a key supplier of specialized immunological and pharmaceutical products for federal medical supply chains.
Quick answers
Who was awarded contract SPE2DR26FQS9W?
SPE2DR26FQS9W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FQS9W worth?
The government has obligated $8,669 on SPE2DR26FQS9W.
Is contract SPE2DR26FQS9W an order under another contract?
Yes. SPE2DR26FQS9W is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQS9W competed?
The extent of competition for SPE2DR26FQS9W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award